Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-3-31
pubmed:abstractText
To evaluate the response rate, survival, and toxicities of paclitaxel plus cisplatin combination in patients with advanced or metastatic squamous-cell carcinoma of the esophagus.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1537-453X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
29-33
pubmed:meshHeading
pubmed-meshheading:18376224-Adult, pubmed-meshheading:18376224-Aged, pubmed-meshheading:18376224-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18376224-Bone Neoplasms, pubmed-meshheading:18376224-Carcinoma, Squamous Cell, pubmed-meshheading:18376224-Chemotherapy, Adjuvant, pubmed-meshheading:18376224-Cisplatin, pubmed-meshheading:18376224-Esophageal Neoplasms, pubmed-meshheading:18376224-Female, pubmed-meshheading:18376224-Follow-Up Studies, pubmed-meshheading:18376224-Humans, pubmed-meshheading:18376224-Liver Neoplasms, pubmed-meshheading:18376224-Lung Neoplasms, pubmed-meshheading:18376224-Male, pubmed-meshheading:18376224-Middle Aged, pubmed-meshheading:18376224-Neoplasm Recurrence, Local, pubmed-meshheading:18376224-Paclitaxel, pubmed-meshheading:18376224-Survival Rate
pubmed:year
2008
pubmed:articleTitle
A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus.
pubmed:affiliation
Department of Gastrointestinal Medicine, Peking University School of Oncology, Beijing Institute for Cancer Research, Beijing Cancer Hospital, Beijing, China.
pubmed:publicationType
Journal Article, Clinical Trial, Phase II